Hevia Cosmetic Dermatology posts a short clip of Dr. Oscar Hevia giving his take on the experimental GLP-1 drug retatrutide.
Recap by typeshit. Post by Hevia Cosmetic Dermatology on Instagram.
8:09
Regan Archibald gives his take on the timeline for retatrutide reaching patients. Tap through for his view on where the drug stands.
Morse says bar and restaurant workers have seen younger adults drink less, framing it as a broad change in the alcohol industry.
Bazaar India's new issue looks at collagen loss and skin laxity concerns tied to fast GLP-1 weight loss, and how beauty brands are responding.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Balwinder Singh and Raman Baweja link GLP-1 use to less kidney replacement therapy in bipolar patients with CKD, and flag lithium toxicity cases.
Bikman argues the facial change reflects rapid weight loss in general and suggests using the drug as a short-term aid for carb cravings. His view, not settled fact.
Loading…